Abstract
Introduction
In 1977 A.D German cardiologist Andreas Gruentzig (1939-85) introduce Percutaneous trans-luminal coronary angioplasty (PTCA) as a non surgical procedure used to dilate narrowed coronary arteries 1 . This procedure is now referred to as Percutaneous coronary intervention (PCI) as this term include the use of balloon, insertion of intra coronary stent and atherectomy device. Since it's introduction, PCI has dramatically changed the modalities of treatment in coronary artery disease (CAD) and effectively replace the need for coronary artery bypass graft surgery (CABG) 2 .
Now a days stent insertion along with angioplasty is a routine procedure in treatment of CAD because evidence suggest that stent implantation enhances the procedural success and durability of angioplasty. With the operator experience, new technology and adjunctive pharmacotherapy the overall success and complication rate of PCI have improved 3 . This modern effective procedure is introduce in our country for a last few years. As far our knowledge, regarding outcome of this procedure no complete study were done in peripheral cath centre of Bangladesh rather than a few study were conducted centrally. North east medical college hospital (NEMCH) is a medical institute in Sylhet, Bangladesh has a well established cath lab centre in cardiology unit were routinely performed coronary angiogram (CAG), percutaneous trans-luminal mitral commissurotomy and PCI etc. This study is a result of immediate outcome of percutaneous coronary intervention (PCI) in 100 cases of this newly setup cath centre. Left main lesion 2.
Materials and Methods
Stent re-stenosis 3.
Bifurcation lesion 4.
Pregnant women 5.
Contraindication for aspirin and clopidegrol therapy 2. Study procedure Before stent implantation, patient were treated with aspirin 300 mg and clopidogrel 300 mg at least 12 hrs before the procedure. A bolus of 10000 unit heparin was given after sheath insertion, with repeat boluses of heparin given as needed to maintain an ACT >250 sec. Different typed (BMS, cobalt, DES) of stents were used. All stents were premounted on a delivery system. Most of the stents were inflated at high pressure (>14 atm) for final in stent dilatation. Post dilatation were performed within the stent to obtain a near zero residual stenosis in few cases. After stent implantation, patient were treated with heparin, started 2 to 3 hrs after sheath removal and continue for 12 hrs in uncomplicated cases and 48 hrs in CTO. Clopidogrel 150 mg was given for 12 months and aspirin 150 mg indefinitely.
The vessel and lesions were analyzed using a computerized quantitative analysis system (QCA-CMS version). Measurement included the interpolated reference diameter, minimal luminal diameter, percent diameter, percent diameter stenosis and lesion length were obtained from the angiogram at baseline and after stent implantation. Lesions were characterized according to the modified AHA/ACC classification. Figure 1 showed Balloon dilatation and placement of stent in the site of atherosclerotic segment. 
II. Procedural success
A successful PCI should achieve angiographic success without in hospital major clinical complications (e.g. death, MI, emergency CABG, during hospitalization).
III. Clinical success
A clinically successful PCI includes anatomic and procedural success with relief of signs and or symptoms of myocardial ischaemia after the patient recovers from procedure. Un-eventful 92%
IV. Procedural complications

Discussion
Now a days, during performing percutaneous coronary revascularization, supplementation of a stent is a routine practice 4 . Study reveals that stent implantation enhances the procedural success and durability of angioplasty in term of reduction in the incidence of lesion recurrence and reduced need for repeat revascularization and lower rates of peri-procedural myocardial infarction (MI) [5] [6] [7] [8] .
Patient enrolled in this study were the routine patients admitted in NEMCH with acute chest pain suggestive of acute coronary syndrome (ACS) and stabilization by medical therapy for at least 3 days, known IHD patient for routine PCI and patient admitted with a view to CAG and subsequently consent for PCI were include in this study.
The main objective of this of this study is an attempt to summarize the initial experience of PCI in 100 consecutive patients with emphasis on clinical success and MACE starting from the procedure & upto 30 days follow-up in a peripheral cath lab of Bangladesh. With the improvements in procedural success due to stents and newer pharmacological strategies, there has been a reduction in complications and the need for emergency CABG with current rates 00% in this study to 0.3% in other investigators 3 .
The present study provides a relatively short period follow-up. Event free survival at 30 days was present in 92 patients (92%) which are almost similar to many national and international studies 11, [18] [19] [20] [21] . 
